Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis.
Department of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, Australia. 1darren1@gmail.com
Darren M
DM
Roberts
Geoffrey
G
Kauter
John E
JE
Ray
Adrian G
AG
Gillin
D000935:Antifungal Agents / Q000008:administration & dosage; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology; D001230:Aspergillus / Q000302:isolation & purification*; D005500:Follow-Up Studies; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D011743:Pyrimidines / Q000008:administration & dosage*; D014230:Triazoles / Q000008:administration & dosage*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole